BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 35834269)

  • 1. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.
    Qiao H; Tan XR; Li H; Li JY; Chen XZ; Li YQ; Li WF; Tang LL; Zhou GQ; Zhang Y; Liang YL; He QM; Zhao Y; Huang SY; Gong S; Li Q; Ye ML; Chen KL; Sun Y; Ma J; Liu N
    JAMA Oncol; 2022 Sep; 8(9):1301-1309. PubMed ID: 35834269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Association of Hepatitis B Surface Antigen and Plasma Epstein-Barr Virus DNA Load on Distant Metastasis in Patients With Nasopharyngeal Carcinoma.
    Li H; Cao D; Li S; Chen B; Zhang Y; Zhu Y; Luo C; Lin W; Huang W; Ruan G; Zhang R; Li J; Liu L
    JAMA Netw Open; 2023 Feb; 6(2):e2253832. PubMed ID: 36757699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection.
    Liu YP; Li H; You R; Li JB; Liu XK; Yang AK; Guo X; Song M; Zhang Q; Guo ZM; Chen WK; Liu WW; Zou X; Hua YJ; Yang Q; Zhang YN; Sun R; Mo HY; Guo L; Lin AH; Mai HQ; Qian CN; Chen MY
    Laryngoscope; 2019 Feb; 129(2):387-395. PubMed ID: 30325027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
    Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
    Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system].
    Mao YP; Hong MH; Sun Y; Liang SB; Li L; Liu LZ; Tang LL; Cao SM; Lin AH; Lu TX; Liu MZ; Ma J
    Ai Zheng; 2007 Oct; 26(10):1099-106. PubMed ID: 17927881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.
    Zhang Y; Zhang ZC; Li WF; Liu X; Liu Q; Ma J
    Oral Oncol; 2019 Aug; 95():150-156. PubMed ID: 31345383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma.
    Zhang LL; Huang MY; Li Y; Liang JH; Gao TS; Deng B; Yao JJ; Lin L; Chen FP; Huang XD; Kou J; Li CF; Xie CM; Lu Y; Sun Y
    EBioMedicine; 2019 Apr; 42():270-280. PubMed ID: 30928358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographical disparities in the prognosis of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a large institution-based cohort study from an endemic area.
    Lin ST; Meng DF; Yang Q; Wang W; Peng LX; Zheng LS; Qiang YY; Mei Y; Xu L; Li CZ; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Li HF; Huang BJ; Qian CN; Sun R
    BMJ Open; 2020 Nov; 10(11):e037150. PubMed ID: 33172940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020.
    Liang YJ; Liu LT; Li Y; Wang P; Luo MJ; Wen DX; Chen QY; Mai HQ
    JAMA Netw Open; 2022 Mar; 5(3):e220173. PubMed ID: 35234882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study.
    Almangush A; Ruuskanen M; Hagström J; Hirvikoski P; Tommola S; Kosma VM; Nieminen P; Mäkitie A; Leivo I
    Hum Pathol; 2018 Nov; 81():211-219. PubMed ID: 30030117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma.
    Shen L; Li W; Wang S; Xie G; Zeng Q; Chen C; Shi F; Zhang Y; Wu M; Shu W; Pan C; Xia Y; Wu P
    Radiology; 2016 Sep; 280(3):805-14. PubMed ID: 27023116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma.
    Li WZ; Wu HJ; Lv SH; Hu XF; Liang H; Liu GY; Lu N; Bei WX; Lv X; Guo X; Xia WX; Xiang YQ
    JAMA Netw Open; 2021 Sep; 4(9):e2124721. PubMed ID: 34554238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Therapeutic Outcome and Prognostic Factors of Patients with Nasopharyngeal Carcinoma Receiving Intensity-modulated Radiotherapy: An Analysis of 608 Patients from Low-endemic Regions of China.
    Huang J; Yang ZY; Wu B; Ding Q; Qin Y; Zhang ZJ; Yin ZY; Liang ZW; Han J; Wang Y; Peng ZJ; Peng G; Li Q; Wu G; Yang KY
    Curr Med Sci; 2021 Aug; 41(4):737-745. PubMed ID: 34403099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
    Deng YF; Zhou DN; Pan ZY; Yin P
    Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma].
    Mao YP; Li WF; Chen L; Sun Y; Liu LZ; Tang LL; Cao SM; Lin AH; Hong MH; Lu TX; Liu MZ; Li L; Ma J
    Ai Zheng; 2009 Oct; 28(10):1022-8. PubMed ID: 19799808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of retropharyngeal lymph node metastasis in staging of nasopharyngeal carcinoma].
    Tang LL; Liu LZ; Ma J; Zong JF; Huang Y; Lin AH; Lu TX; Cui NJ
    Ai Zheng; 2006 Feb; 25(2):129-35. PubMed ID: 16480573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.
    Chen C; Zhou Y; Zhang X; Fu S; Lin Z; Fang W; Yang Y; Huang Y; Zhao H; Hong S; Zhang L
    Cancer Med; 2020 Mar; 9(5):1721-1732. PubMed ID: 31955525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.
    Li J; Zou X; Wu YL; Guo JC; Yun JP; Xu M; Feng QS; Chen LZ; Bei JX; Zeng YX; Chen MY
    PLoS One; 2014; 9(12):e116261. PubMed ID: 25536307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.